[6] MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation ,
The formulation combines Glycyl-L-histidyl-L-lysine copper(II) (GHK-Cu), Body Protection Compound-157 (BPC-157), Thymosin Beta-4 derivative (TB500), and the naturally occurring alpha-MSH cleavage derivative, KPV
Both hold PCAB and NABP accreditations
Epithalon is administered in defined cycles of ten to twenty days with rest periods between them, responding to pulse-dosing rather than continuous daily administration due to its mechanism of telomere regulation and circadian rhythm modulation
While it went by multiple names the pharmacy in question tended to use some variation of The Compounding Pharmacy of Australia, in what may have been an attempt to appear legitimate upon a cursory Google search
The harder lessons are methodological, and they shape what the next round of trials should look like